Advances in the Management of Excessive Daytime Sleepiness and Narcolepsy

EP. 1: Narcolepsy Overview
ByMichael J. Thorpy, MD,Thomas Scammell, MD,Karl Doghramji, MD,Anne Marie Morse, DO, FAASM ,Debra Stultz, MD Experts provide an overview of excessive daytime sleepiness and narcolepsy.

EP. 2: Burden and Risk Factor of Narcolepsy
ByMichael J. Thorpy, MD,Thomas Scammell, MD,Karl Doghramji, MD,Anne Marie Morse, DO, FAASM ,Debra Stultz, MD Anne Marie Morse, DO, FAASM, discusses the burden and risk factors associated with excessive daytime sleepiness and narcolepsy.

EP. 3: Diagnosis of Narcolepsy
ByMichael J. Thorpy, MD,Thomas Scammell, MD,Karl Doghramji, MD,Anne Marie Morse, DO, FAASM ,Debra Stultz, MD Experts discuss narcolepsy diagnosis and the challenges associated with it.

EP. 4: EDS Evaluation
ByMichael J. Thorpy, MD,Thomas Scammell, MD,Karl Doghramji, MD,Anne Marie Morse, DO, FAASM ,Debra Stultz, MD Thomas E. Scammell, MD, discusses evaluating excessive daytime sleepiness (EDS).

EP. 5: Available Resources for Narcolepsy Treatment
ByMichael J. Thorpy, MD,Thomas Scammell, MD,Karl Doghramji, MD,Debra Stultz, MD ,Anne Marie Morse, DO, FAASM Debra Stultz, MD, provides an overview of the available resources that are available for narcolepsy treatment.

EP. 6: Goals of Therapy for Narcolepsy
ByMichael J. Thorpy, MD,Thomas Scammell, MD,Karl Doghramji, MD,Anne Marie Morse, DO, FAASM ,Debra Stultz, MD Neurology experts describe the goals of therapy for narcolepsy treatment.

EP. 7: Pharmacological Treatment Options for Narcolepsy
ByMichael J. Thorpy, MD,Thomas Scammell, MD,Karl Doghramji, MD,Anne Marie Morse, DO, FAASM ,Debra Stultz, MD Karl Doghramji, MD, FAASM, DFAPA, provides an overview of the pharmacological treatment options for narcolepsy.

EP. 8: EDS and Narcolepsy Treatment Options
ByMichael J. Thorpy, MD,Thomas Scammell, MD,Karl Doghramji, MD,Anne Marie Morse, DO, FAASM ,Debra Stultz, MD Neurology experts discuss excessive daytime sleepiness (EDS) and narcolepsy treatment options.

EP. 9: Pitolisant: Mechanism of Action
ByMichael J. Thorpy, MD,Thomas Scammell, MD,Karl Doghramji, MD,Anne Marie Morse, DO, FAASM ,Debra Stultz, MD Thomas E. Scammell, MD, provides an overview of the mechanism of action of pitolisant for the treatment of narcolepsy.

EP. 10: Pitolisant Efficacy and Safety
ByMichael J. Thorpy, MD,Thomas Scammell, MD,Karl Doghramji, MD,Anne Marie Morse, DO, FAASM ,Debra Stultz, MD Anne Marie Morse, DO, FAASM, discusses the efficacy and safety profile of pitolisant for the treatment of narcolepsy.

EP. 11: Solriamfetol Efficacy and Safety
ByMichael J. Thorpy, MD,Thomas Scammell, MD,Karl Doghramji, MD,Anne Marie Morse, DO, FAASM ,Debra Stultz, MD Experts discuss the efficacy and safety profile of solriamfetol for the treatment of narcolepsy.

EP. 12: Sodium Oxybate and Antidepressants for Treatment of Cataplexy
ByMichael J. Thorpy, MD,Thomas Scammell, MD,Karl Doghramji, MD,Anne Marie Morse, DO, FAASM ,Debra Stultz, MD Experts discuss sodium oxybate and antidepressants for treatment of cataplexy.

EP. 13: Unmet Needs in Narcolepsy and Clinical Pearls
ByMichael J. Thorpy, MD,Thomas Scammell, MD,Karl Doghramji, MD,Anne Marie Morse, DO, FAASM ,Debra Stultz, MD Neurology experts discuss the unmet needs in narcolepsy treatment and share clinical pearls from their experiences.